Analysis of residual solvents in poly(lactide-co-glycolide) nanoparticles

Journal of Pharmaceutical Investigation

Volumn 42, Issue 5, 2012, Pages 251-256

  Han, Eun Jung ^a,b   Chung, Ae Hee ^a   Oh, In Joon ^b  

^a Seoul National University Boramae Hospital   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Dichloromethane; Nanoparticles; PLGA; Residual solvents; Toxicity

Indexed keywords

DICHLOROMETHANE; NANOPARTICLE; POLYGLACTIN; SURFACTANT;

ACCURACY; ARTICLE; CONCENTRATION; DRUG DELIVERY SYSTEM; EMULSION; GAS CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PARTICLE SIZE; PRIORITY JOURNAL; RISK; SAFETY; STANDARDIZATION; TEMPERATURE; VALIDATION PROCESS;

EID: 84876543512     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-012-0034-3     Document Type: Article

References (26)

1. Antolin EM, Quinonez YB, Canavaciolo VG, Cruz ER (2008) Validation of an analytical method for quality control of residual solvents (n-hexane and acetone) in D-002: new active ingredient from beeswax. J Pharm Biomed Anal 47: 623-638.
2. Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted system for cancer therapy. Adv Drug Deliv Rev 56: 1649-1659.
3. Budhian A, Siegel SJ, Winey KI (2007) Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm 336: 367-375.
4. 18F]FDG by GC. Nucl Med Biol 28: 469-471.
5. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC (2007) Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28: 869-876.
6. Galanalis EG, Megoulas NC, Solich P, Koupparis MA (2006) Development and validation of a novel LC non-derivatization method for the determination of amikacin in pharmaceuticals base on evaporative light scattering detection. J Pharm Biomed Anal 40: 1114-1120.
7. Herberger J, Murphy K, Munyakazi L, Cordia J, Westhaus E (2003) Carbon dioxide extraction of residual solvents in poly(lactide-co-glycolide) microparticles. J Control Release 90: 181-195.
8. Huber L (1999) Validation and qualification in analytical laboratories. Interpharm Press, Buffalo Grove, pp 107-140.
9. Jain RA (2000) The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21: 2475-2490.
10. Kang Y, Yin G, Ouyang P, Huang Z, Yao Y, Liao X, Chen A, Pu X (2008) Preparation of PLLA/PLGA microparticles using solution enhanced dispersion by supercritical fluids (SEDS). J Colloid Interface Sci 322: 87-94.
11. Kawashima Y, Yamamoto H, Takeuchi H, Hino T, Niwa T (1998) Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur J Pharm Biopharm 45: 41-48.
12. Koushik K, Komepella UB (2004) Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process. Pharm Res 21: 524-535.
13. Krizman M, Baricevic D, Prosek M (2006) Fast quantitative determination of volatile constituents in fennel by headspace-gas chromatography. Anal Chim Acta 557: 267-271.
14. Lakatos M (2008) Measurement of residual solvents in a drug substance by a purge-and-trap method. J Pharm Biomed Anal 47: 954-957.
15. Lee LY, Wang CH, Smith KA (2008) Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel. J Control Release 125: 96-106.
16. Legrand P, Lesieur S, Bochot A, Gref R, Raatjes W, Barratt G, Vauthier C (2007) Influence of polymer behavior in organic solution on the production of polylactide nanoparticles by nanoprecipitation. Int J Pharm 344: 33-43.
17. Liu Y, Hu CQ (2006) Establishment of a knowledge base for identification of residual solvents in pharmaceuticals. Anal Chim Acta 575: 246-254.
18. Liu Y, Hu CQ (2007) Preliminary identification and quantification of residual solvents in pharmaceuticals using the parallel dual-column system. J Chromatogr A 1175: 259-266.
19. Meng FT, Ma GH, Qiu W, Su ZG (2003) W/O/W double emulsion technique using ethyl acetate as organic solvent: effects of its diffusion rate on the characteristics of microparticles. J Control Release 91: 407-416.
20. Miller JM, Crowther JB (2000) Analytical chemistry in a GMP environment. John & Sons, New York, pp 444-449.
21. Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target specific nanoparticles. Pharmacol Rev 53: 283-318.
22. Otero R, Carrera G, Dulsat JF, Fabregas JL, Claramunt J (2004) Static headspace gas chromatographic method for quantitative determination of residual solvents in pharmaceutical drug substances according to European Pharmacopoeia requirements. J Chromatogr A 1057: 193-201.
23. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55: 329-347.
24. Rocheleau MJ, Titley M, Bolduc J (2004) Measuring residual solvents in pharmaceutical samples using fast gas chromatography techniques. J Chromatogr B 805: 73-86.
25. Ruchatz F, Kleinebudde P, Muller BW (1996) Residual solvents in biodegradable microparticles: determination by a dynamic headspace gas chromatographic method. Int J Pharm 142: 67-73.
26. Sitaramaraju Y, Riadi A, D'Autry W, Wolfs K, Hoogmartens J, Schepdael AV, Adams E (2008) Evaluation of the European Pharmacopoeia method for control of residual solvents in some antibiotics. J Pharm Biomed Anal 48: 113-119.